- Home
- BIO vs TPG Comparison
BIO vs TPG Comparison
Compare BIO & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- TPG
- Stock Information
- Founded
- BIO 1952
- TPG 1992
- Country
- BIO United States
- TPG United States
- Employees
- BIO N/A
- TPG N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- TPG Investment Managers
- Sector
- BIO Industrials
- TPG Finance
- Exchange
- BIO Nasdaq
- TPG Nasdaq
- Market Cap
- BIO 6.0B
- TPG 6.2B
- IPO Year
- BIO N/A
- TPG 2022
- Fundamental
- Price
- BIO $243.98
- TPG $52.49
- Analyst Decision
- BIO Strong Buy
- TPG Buy
- Analyst Count
- BIO 4
- TPG 13
- Target Price
- BIO $324.25
- TPG $62.17
- AVG Volume (30 Days)
- BIO 417.7K
- TPG 1.8M
- Earning Date
- BIO 07-31-2025
- TPG 08-05-2025
- Dividend Yield
- BIO N/A
- TPG 3.33%
- EPS Growth
- BIO N/A
- TPG N/A
- EPS
- BIO N/A
- TPG N/A
- Revenue
- BIO $2,541,100,000.00
- TPG $3,710,887,000.00
- Revenue This Year
- BIO N/A
- TPG N/A
- Revenue Next Year
- BIO $3.49
- TPG $23.44
- P/E Ratio
- BIO N/A
- TPG N/A
- Revenue Growth
- BIO N/A
- TPG 44.34
- 52 Week Low
- BIO $211.43
- TPG $37.52
- 52 Week High
- BIO $387.99
- TPG $72.98
- Technical
- Relative Strength Index (RSI)
- BIO 60.94
- TPG 63.47
- Support Level
- BIO $235.01
- TPG $48.75
- Resistance Level
- BIO $246.50
- TPG $53.02
- Average True Range (ATR)
- BIO 7.17
- TPG 1.51
- MACD
- BIO 2.32
- TPG 0.23
- Stochastic Oscillator
- BIO 90.49
- TPG 95.40
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.